
Opinion|Videos|May 28, 2024
Hepatic Encephalopathy: Critical Insights and Closing Thoughts
In their concluding remarks, Arun Jesudian, MD; Ralph J. Riello, PharmD, BCPS, and Chas McCormick, RPh, MBA, summarize the key takeaways and highlight the persistent unmet needs in the management of hepatic encephalopathy.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Earlier Menopause, Reduced Cardiac Function Potentially Linked With Negative Impacts on Brain Health
2
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
3
Menopause Care Varies by Provider, Highlighting Need for Standardized Education
4
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms
5















































































































































































































